
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Susan Zelasko, William R. Arnold, Aditi Das
Prostaglandins & Other Lipid Mediators (2014) Vol. 116-117, pp. 112-123
Closed Access | Times Cited: 58
Susan Zelasko, William R. Arnold, Aditi Das
Prostaglandins & Other Lipid Mediators (2014) Vol. 116-117, pp. 112-123
Closed Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
Cannabinoids and Cytochrome P450 Interactions
Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, et al.
Current Drug Metabolism (2016) Vol. 17, Iss. 3, pp. 206-226
Closed Access | Times Cited: 244
Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, et al.
Current Drug Metabolism (2016) Vol. 17, Iss. 3, pp. 206-226
Closed Access | Times Cited: 244
Immune Responses Regulated by Cannabidiol
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188
Targeting the endocannabinoid system: future therapeutic strategies
Oier Aizpurua‐Olaizola, Izaskun Elezgarai, Irantzu Rico‐Barrio, et al.
Drug Discovery Today (2016) Vol. 22, Iss. 1, pp. 105-110
Open Access | Times Cited: 185
Oier Aizpurua‐Olaizola, Izaskun Elezgarai, Irantzu Rico‐Barrio, et al.
Drug Discovery Today (2016) Vol. 22, Iss. 1, pp. 105-110
Open Access | Times Cited: 185
THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 52
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 52
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
János Pálóczi, Zoltán V. Varga, George Hasko, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 1, pp. 75-108
Open Access | Times Cited: 96
János Pálóczi, Zoltán V. Varga, George Hasko, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 1, pp. 75-108
Open Access | Times Cited: 96
Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
Josephine E. Watson, Justin Kim, Aditi Das
Prostaglandins & Other Lipid Mediators (2019) Vol. 143, pp. 106337-106337
Open Access | Times Cited: 93
Josephine E. Watson, Justin Kim, Aditi Das
Prostaglandins & Other Lipid Mediators (2019) Vol. 143, pp. 106337-106337
Open Access | Times Cited: 93
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91
Keith Cheung, Hassendrini N. Peiris, Geoff Wallace, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6079-6079
Open Access | Times Cited: 91
Cannabis and Cannabinoids: Kinetics and Interactions
Brian C. Foster, Hanan Abramovici, Cory S. Harris
The American Journal of Medicine (2019) Vol. 132, Iss. 11, pp. 1266-1270
Closed Access | Times Cited: 88
Brian C. Foster, Hanan Abramovici, Cory S. Harris
The American Journal of Medicine (2019) Vol. 132, Iss. 11, pp. 1266-1270
Closed Access | Times Cited: 88
The Role of Omega-3 Polyunsaturated Fatty Acids and Their Lipid Mediators on Skeletal Muscle Regeneration: A Narrative Review
Sebastian Jannas‐Vela, Alejandra Espinosa, Alejandro A. Candia, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 26
Sebastian Jannas‐Vela, Alejandra Espinosa, Alejandro A. Candia, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 26
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
Torsten Lowin, Rainer H. Straub
Arthritis Research & Therapy (2015) Vol. 17, Iss. 1
Open Access | Times Cited: 77
Torsten Lowin, Rainer H. Straub
Arthritis Research & Therapy (2015) Vol. 17, Iss. 1
Open Access | Times Cited: 77
Fatty acids, endocannabinoids and inflammation
Renger F. Witkamp
European Journal of Pharmacology (2015) Vol. 785, pp. 96-107
Closed Access | Times Cited: 72
Renger F. Witkamp
European Journal of Pharmacology (2015) Vol. 785, pp. 96-107
Closed Access | Times Cited: 72
Interplay Between n‐3 and n‐6 Long‐Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair
Simon C. Dyall
Lipids (2017) Vol. 52, Iss. 11, pp. 885-900
Open Access | Times Cited: 71
Simon C. Dyall
Lipids (2017) Vol. 52, Iss. 11, pp. 885-900
Open Access | Times Cited: 71
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
Alimuddin Zumla, Martin Rao, Ernest Dodoo, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 65
Alimuddin Zumla, Martin Rao, Ernest Dodoo, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 65
Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
Tim Ambrose, Alison Simmons
Journal of Crohn s and Colitis (2018) Vol. 13, Iss. 4, pp. 525-535
Open Access | Times Cited: 61
Tim Ambrose, Alison Simmons
Journal of Crohn s and Colitis (2018) Vol. 13, Iss. 4, pp. 525-535
Open Access | Times Cited: 61
Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
Anna Lisa Brigida, Stephen Schultz, Mariana Cascone, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 54
Anna Lisa Brigida, Stephen Schultz, Mariana Cascone, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1425-1425
Open Access | Times Cited: 54
n–3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer
Cinzia Giordano, Pierluigi Plastina, Ines Barone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2279-2279
Open Access | Times Cited: 42
Cinzia Giordano, Pierluigi Plastina, Ines Barone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2279-2279
Open Access | Times Cited: 42
CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design
Aditi Das, Austin T. Weigle, William R. Arnold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107601-107601
Open Access | Times Cited: 39
Aditi Das, Austin T. Weigle, William R. Arnold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107601-107601
Open Access | Times Cited: 39
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2
William R. Arnold, Austin T. Weigle, Aditi Das
Journal of Inorganic Biochemistry (2018) Vol. 184, pp. 88-99
Open Access | Times Cited: 46
William R. Arnold, Austin T. Weigle, Aditi Das
Journal of Inorganic Biochemistry (2018) Vol. 184, pp. 88-99
Open Access | Times Cited: 46
Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
John R. Richards
Medical Hypotheses (2017) Vol. 103, pp. 90-95
Closed Access | Times Cited: 42
John R. Richards
Medical Hypotheses (2017) Vol. 103, pp. 90-95
Closed Access | Times Cited: 42
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Edward Chesney, Dominic Oliver, Philip McGuire
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1179-1190
Open Access | Times Cited: 32
Edward Chesney, Dominic Oliver, Philip McGuire
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1179-1190
Open Access | Times Cited: 32
Perinatal CBD or THC Exposure Results in Lasting Resistance to Fluoxetine in the Forced Swim Test: Reversal by Fatty Acid Amide Hydrolase Inhibition
Izaque de Sousa Maciel, Gabriel H Dias de Abreu, Claire T. Johnson, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 3, pp. 318-327
Open Access | Times Cited: 27
Izaque de Sousa Maciel, Gabriel H Dias de Abreu, Claire T. Johnson, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 3, pp. 318-327
Open Access | Times Cited: 27
Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase
William R. Arnold, Javier L. Baylon, Emad Tajkhorshid, et al.
Biochemistry (2016) Vol. 55, Iss. 50, pp. 6969-6980
Open Access | Times Cited: 33
William R. Arnold, Javier L. Baylon, Emad Tajkhorshid, et al.
Biochemistry (2016) Vol. 55, Iss. 50, pp. 6969-6980
Open Access | Times Cited: 33